Jeppson Wealth Management LLC Has $2.14 Million Stock Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Jeppson Wealth Management LLC decreased its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 1.1% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 52,608 shares of the real estate investment trust’s stock after selling 608 shares during the period. Jeppson Wealth Management LLC’s holdings in Omega Healthcare Investors were worth $2,141,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in shares of Omega Healthcare Investors by 0.5% in the first quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust’s stock worth $1,120,478,000 after purchasing an additional 165,105 shares in the last quarter. Caxton Associates LP acquired a new stake in Omega Healthcare Investors in the 2nd quarter valued at $1,652,000. Van ECK Associates Corp lifted its position in Omega Healthcare Investors by 15.4% during the 3rd quarter. Van ECK Associates Corp now owns 100,145 shares of the real estate investment trust’s stock worth $4,167,000 after buying an additional 13,367 shares in the last quarter. Cetera Advisors LLC acquired a new position in shares of Omega Healthcare Investors during the 1st quarter worth about $646,000. Finally, Assetmark Inc. grew its holdings in shares of Omega Healthcare Investors by 1.7% in the 3rd quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust’s stock valued at $48,492,000 after acquiring an additional 19,542 shares in the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

Shares of OHI opened at $41.39 on Tuesday. The company’s 50-day moving average is $40.59 and its 200-day moving average is $36.40. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The firm has a market capitalization of $11.17 billion, a PE ratio of 30.43, a PEG ratio of 1.33 and a beta of 0.99. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $44.42.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be issued a $0.67 dividend. The ex-dividend date of this dividend is Monday, November 4th. This represents a $2.68 annualized dividend and a yield of 6.47%. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Insiders Place Their Bets

In other news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a report on Thursday, October 31st. Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Royal Bank of Canada raised their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research note on Monday. Scotiabank boosted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. Finally, BMO Capital Markets increased their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research note on Monday, October 7th. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $40.00.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.